Article
The importance of ancestry to understanding tumor mutation burden in cancer.
Cancer cell - 10 Oct 2022
Snyder Alexandra, McGranahan Nicholas
Abstract excerpt
In the current issue of Cancer Cell, Nassar and colleagues find that in solid tumors, tumor-only sequencing leads to an overestimate of the biomarker tumor mutation burden (TMB), particularly in patients of African or Asian ancestry. Correction of the TMB estimate improves the correlation between TMB and response to immunotherapy.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.